1. Home
  2. HIMX vs ARQT Comparison

HIMX vs ARQT Comparison

Compare HIMX & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HIMX
  • ARQT
  • Stock Information
  • Founded
  • HIMX 2001
  • ARQT 2016
  • Country
  • HIMX Taiwan
  • ARQT United States
  • Employees
  • HIMX N/A
  • ARQT N/A
  • Industry
  • HIMX Semiconductors
  • ARQT Biotechnology: Pharmaceutical Preparations
  • Sector
  • HIMX Technology
  • ARQT Health Care
  • Exchange
  • HIMX Nasdaq
  • ARQT Nasdaq
  • Market Cap
  • HIMX 1.5B
  • ARQT 1.7B
  • IPO Year
  • HIMX 2006
  • ARQT 2020
  • Fundamental
  • Price
  • HIMX $9.33
  • ARQT $15.00
  • Analyst Decision
  • HIMX Buy
  • ARQT Strong Buy
  • Analyst Count
  • HIMX 1
  • ARQT 6
  • Target Price
  • HIMX $15.00
  • ARQT $18.80
  • AVG Volume (30 Days)
  • HIMX 1.3M
  • ARQT 2.0M
  • Earning Date
  • HIMX 08-07-2025
  • ARQT 08-13-2025
  • Dividend Yield
  • HIMX 3.94%
  • ARQT N/A
  • EPS Growth
  • HIMX 87.58
  • ARQT N/A
  • EPS
  • HIMX 0.50
  • ARQT N/A
  • Revenue
  • HIMX $914,385,000.00
  • ARQT $212,819,000.00
  • Revenue This Year
  • HIMX N/A
  • ARQT $61.15
  • Revenue Next Year
  • HIMX $7.15
  • ARQT $37.98
  • P/E Ratio
  • HIMX $18.60
  • ARQT N/A
  • Revenue Growth
  • HIMX 0.62
  • ARQT 100.03
  • 52 Week Low
  • HIMX $5.12
  • ARQT $7.86
  • 52 Week High
  • HIMX $13.91
  • ARQT $17.75
  • Technical
  • Relative Strength Index (RSI)
  • HIMX 57.28
  • ARQT 60.23
  • Support Level
  • HIMX $8.99
  • ARQT $13.06
  • Resistance Level
  • HIMX $9.50
  • ARQT $15.36
  • Average True Range (ATR)
  • HIMX 0.36
  • ARQT 0.66
  • MACD
  • HIMX -0.03
  • ARQT 0.12
  • Stochastic Oscillator
  • HIMX 61.20
  • ARQT 82.57

About HIMX Himax Technologies Inc.

Himax Technologies Inc is a semiconductor solution provider dedicated to display imaging processing technologies. It operates through the Driver Integrated Circuit and Non-Driver Products segments. The majority of the firm's revenue is derived from the Driver Integrated Circuit segment. It offers display driver ICs and timing controllers used in TVs, laptops, monitors, mobile phones, tablets, digital cameras, virtual reality (VR) devices, and many other consumer electronics devices. It also designs and provides controllers for touch sensor displays, in-cell Touch and Display Driver Integration single-chip solutions, LED driver ICs, power management ICs, and scaler products for monitors and projectors. Geographically, it generates the majority of its revenue from China.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

Share on Social Networks: